Video

Industry Leaders Panel Discussion: Patient Access Organizations

Panel Discussion: The Future of Patient Access Organizations (PAOs) 
 

An in-depth panel discussion on the evolution of clinical trial site organizations into  Patient Access Organizations (PAOs), and their growing influence in clinical research. Watch as our expert panelists share their insights on the challenges, opportunities, and future trends shaping the PAO landscape. 

Our Expert Panelists: 

  • Jennifer Byrne, Founder & CEO of Javara  

Why watch? 

This panel provides critical insights for industry professionals navigating the future of clinical research. Whether you’re in pharma, a clinical trial site, or looking to partner with PAOs, this discussion will offer valuable perspectives to help you stay ahead in an evolving market. 

Key Topics Covered: 

  • The Future of Market Share: Discover where market share might shift in the next decade. Will we see a rise in 20-30 scaled networks, a few dominant players, or a consolidation into CROs? We'll also explore the competitive landscape between AMCs, commercial site networks, and smaller, independent operators. 
  • Building Pharma Partnerships: Learn how Patient Access Organizations (PAOs) can forge lasting partnerships with pharmaceutical giants. Our discussion will cover the evolving contracting landscape and the role of additional services in fostering stronger collaborations. 
  • Patient Recruitment Strategies: As clinical trials transform, recruitment methods are evolving too. Will EMR integrations become the norm, or will traditional advertising still hold value? We’ll discuss the future of centralized patient recruitment and its potential integration into global site networks. 
  • Operating Models for Clinical Trial Sites: What’s next for clinical trial site operations? Our panel will delve into whether the balance of independent vs. embedded sites will persist and how this dynamic may shift over the coming years. 
  • Therapeutic Area Specialization: Will PAOs continue to be therapeutic-area agnostic, or will they specialize around key opinion leader (KOL) alignments in specific areas? We’ll explore current trends and future predictions in this space. 
  • PAOs vs. CROs: Explore the evolving relationship between PAOs and CROs. Will they continue to collaborate, or will competition intensify as their services start to overlap? 

Watch Now